Corrigendum: Time to clinical improvement: an appropriate surrogate endpoint for pulmonary arterial hypertension medication trials

Front Cardiovasc Med. 2024 Feb 21:11:1371699. doi: 10.3389/fcvm.2024.1371699. eCollection 2024.

Abstract

[This corrects the article DOI: 10.3389/fcvm.2023.1142721.].

Keywords: 6-min walk distance; efficacy; pulmonary arterial hypertension; risk stratification; time to clinical improvement.

Publication types

  • Published Erratum

Grants and funding

This work was supported by the National Natural Science Foundation of China (CN) (81970047, 82270050) and the Clinical Research Innovation and Incubation Foundation of Renji Hospital, Shanghai Jiao Tong University School of Medicine (PYII20-13).